When the American Cancer Society (ACS) announced this week it had shifted its recommendations for mammography, it was sure to prompt a flurry of responses.

When considering at what intervals to be screened for breast cancer, women and their doctors may have a new insight to take into account.

Hypofractionated radiation therapy (RT) has become an intriguing treatment option for cancer thanks to its shortened therapy schedule relative to conventional RT. A recently presented analysis has shown it also largely matches up with conventional RT on cure rates and side effects when used for low-risk prostate cancer.

The American Cancer Society (ACS) has issued new recommendations for screening mammography, urging women of average risk to get annual mammograms starting at age 45, rather than age 40.

A steroidal pain-management treatment used during radiation therapy for bone metastases has made good on its earlier promise, meaningfully outperforming placebo in a double-blind, randomized phase 3 trial. 

Radiologists have been called to communicate directly with patients in order to raise visibility for the specialty and improve care for patients. One Florida breast imaging center is taking this idea to heart.

Mevion Medical Systems is expanding its collaboration with Washington University in St. Louis to study Mevion’s HYPERSCAN pencil beam scanning technology and its effects on the delivery of intensity modulated proton therapy (IMPT) treatment delivery.

Pennsylvania Gov. Tom Wolf announced additional charges for tomosynthesis would no longer be assessed to patients in the state. In response, the editorial board of the Reading Eagle newspaper gave the move “an absolute thumbs-up.”